Smoking cessation and the course of major depression: A follow-up study

Lancet

Volumn 357, Issue 9272, 2001, Pages 1929-1932

  Glassman, Alexander H ^a,b   Covey, Lirio S ^a,b   Stetner, Fay ^a,b   Rivelli, Sarah ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; SERTRALINE;

ADULT; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; SMOKING CESSATION;

EID: 0035897882     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)05064-9     Document Type: Article

References (24)

1. Heavy smokers, smoking cessation and clonidine: Results of a double-blind, randomized trial
2. Smoking, smoking cessation, and major depression
3. Nicotine dependence, major depression, and anxiety in young adults
4. Smoking and major depression: A causal analysis
5. Ever-smoking, quitting, and psychiatric disorders: Evidence from the Durham, North Carolina, epidemiologic catchment area
6. Mood and depression diagnosis in smoking cessation
7. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers
8. Depression and smoking cessation in older adults: A longitudinal study
9. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers
10. Depression and depressive symptoms in smoking cessation
11. Depression after smoking cessation: Case reports
12. Major depression following smoking cessation
13. Development of major depression after treatment for smoking cessation
14. A trial of sertraline for smokers with past major depression
15. Three year outcomes for maintenance therapies in recurrent depression
16. Multiple recurrences of major depressive disorder
17. Continuation drug therapy for major depressive episodes: How long should it be maintained?
18. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
19. Nicotine, negative affect, and depression
20. Development of major depressive disorder during smoking-cessation treatment
21. Presynaptic ionotropic receptors
22. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression